Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wedbush Maintains Neutral on DocuSign, Raises Price Target to $65

Author: Benzinga Newsdesk | March 08, 2024 11:21am
Wedbush analyst Daniel Ives maintains DocuSign (NASDAQ:DOCU) with a Neutral and raises the price target from $56 to $65.

Posted In: DOCU

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist